Professor Annette Byrne was one of eight RCSI researchers to have been awarded a total of €2.8m in the 2019 Health Research Board (HRB) Investigator-Led Projects funding programme. Congratulations, Annette!

The HRB Investigator-Led Projects scheme aims to support highly innovative and internationally competitive research, driven by a vision for improvements in human health and wellbeing. Dr Darrin Morrissey, Chief Executive at the HRB said: “Our Investigator-Led Projects scheme aims to create new knowledge that, over time, will help to address major health challenges in society and have an impact on tomorrow’s healthcare.”

Annette’s project award is titled: “A new cell-free DNA liquid biopsy assay to predict bevacizumab outcome in metastatic colorectal cancer patients”.

Prof Byrne is the Coordinator of COLOSSUS ( View the COLOSSUS explainer video here. Follow the project on Twitter @COLOSSUSEU.

COLOSSUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no 754923. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.